| MyFox Houston |
style = class = “lh”> Alkermes diabetes 27 (Bloomberg) – Amylin Pharmaceuticals Inc. and Alkermes Plc succeeded in her third attempt to win U.S. approval for Bydureon, a once-weekly version of Amylin’s diabetes shot . The Food and Drug Administration approved ‘the drug for adults with type … / font> diabetes drug gets FDA nod drug Diabetes Drug After delays
|